SNAP Message Board - Msg: 14178405

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNAP

SNAP 7.800

+2.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (94)	8/8/2000 12:00:02 AM
From: Mike McFarland	Read Replies (1) of 124

synapticcorp.com "During the second quarter our patent estate continued to grow," commented Kathleen P. Mullinix, Ph.D., chairman, president and chief executive officer. "During the period, we were granted a number of new patents, bringing our current total to 102. In addition, we have been notified by the U.S. Patent and Trademark Office and various foreign patent offices that 15 additional patents will be granted, and we have another 168 patent applications pending before these offices. Also on July 5, we were awarded a patent granting screening claims to another of our adrenergic receptors. This patent is a nice complement to our marketing program for non exclusive licenses to our alpha adrenergic and BPH technologies." http://www.synapticcorp.com/news.htm#08/07/2000 Synaptic Pharmaceutical Reports Second Quarter and Six Months Results Ah, the IP list is helpful: synapticcorp.com Also, there will be a speaker from Synaptic at ddt2k. Noticed Cortex there too--both in Symposium Dhttp://www.drugdisc.com/2000/sched2.asp?view=all

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next